Bexicaserin

Bexicaserin (LP352) is a 5-HT2C receptor agonist with potential for studying obesity and psychiatric-related disorders (such as epilepsy) [1][2].

Product Specifications

CAS Number

[2035818-24-5]

Product Name Alternative

LP352

UNSPSC

12352005

Target

5-HT Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/bexicaserin.html

Purity

99.96

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

FC(F)CNC(C1=C2C3=C(C=C1)CNCCN3C[C@@H]2C)=O

Molecular Formula

C15H19F2N3O

Molecular Weight

295.33

References & Citations

[1]Pędzich BD, et al. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice. Neuropsychopharmacology. 2022 Jun;47 (7) :1304-1314.|[2]Kaye R, et al. Searching for safer and more effective medications in the management of seizure disorders: a 5-HT2C superagonist[C]//EPILEPSIA. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY, 2023, 64: 315-315.